• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗后的凋亡乳腺癌细胞通过具有LAP活性的巨噬细胞诱导促肿瘤细胞外囊泡。

Apoptotic breast cancer cells after chemotherapy induce pro-tumour extracellular vesicles via LAP-competent macrophages.

作者信息

Zhang Qi, Liu Xiaodi, Wei Qiuxia, Xiong Shiyu, Luo Wanrong, Zhou Yingshi, Cao Jincheng, Xu Xiaolin, Liu Rongbin, Tang Xinyu, Zhang Wenyue, Luo Baoming

机构信息

Department of Ultrasound, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Department of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China.

Department of Ultrasound, Laboratory of Ultrasound Imaging and Drug, West China Hospital, Sichuan University, Chengdu, 610041, China.

出版信息

Redox Biol. 2025 Mar;80:103485. doi: 10.1016/j.redox.2024.103485. Epub 2024 Dec 28.

DOI:10.1016/j.redox.2024.103485
PMID:39756316
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11758215/
Abstract

Chemotherapy is important in the systemic therapy for breast cancer. However, after chemotherapy, the left living tumour cells are more progressive. There is an urgent need to study the underlying mechanism which is still unclear to further improve the therapeutic efficacy of chemotherapy in breast cancer. Here we find a pro-tumour effect of the apoptotic cells induced by the chemotherapy, which is mediated by a new subset of macrophages undergoing LC3-associated phagocytosis (LAP). By transferring exosomal S100A11 into the living tumour cells after chemotherapy, the macrophage exhibits a more pro-tumour phenotype than classic M2-type macrophages. Moreover, S100A11 binds to IFITM3, inducing Akt phosphorylation of living tumour cells after chemotherapy, which promotes tumour progression. Of note, Akt inhibitor can enhance the therapeutic effcicay of chemotherapy in breast cancer. This study provides a novel mechanistic link between tumour-associated macrophages and breast cancer, uncovering Akt as a potential therapeutic target to improve chemotherapy efficacy.

摘要

化疗在乳腺癌的全身治疗中至关重要。然而,化疗后残留的存活肿瘤细胞更具侵袭性。迫切需要研究其潜在机制(目前仍不清楚),以进一步提高乳腺癌化疗的疗效。在此,我们发现化疗诱导的凋亡细胞具有促肿瘤作用,这是由经历LC3相关吞噬作用(LAP)的新亚群巨噬细胞介导的。化疗后,通过将外泌体S100A11转移至存活肿瘤细胞中,巨噬细胞表现出比经典M2型巨噬细胞更强的促肿瘤表型。此外,S100A11与IFITM3结合,诱导化疗后存活肿瘤细胞的Akt磷酸化,从而促进肿瘤进展。值得注意的是,Akt抑制剂可增强乳腺癌化疗的疗效。本研究揭示了肿瘤相关巨噬细胞与乳腺癌之间的新型机制联系,发现Akt是提高化疗疗效的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/de6893ea402f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/fa8f4794e417/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/e0ab4ec63a77/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/d520d381c332/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/66cc10c4274c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/bd5a6177262f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/2ef24e800e20/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/de6893ea402f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/fa8f4794e417/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/e0ab4ec63a77/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/d520d381c332/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/66cc10c4274c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/bd5a6177262f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/2ef24e800e20/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a7/11758215/de6893ea402f/gr7.jpg

相似文献

1
Apoptotic breast cancer cells after chemotherapy induce pro-tumour extracellular vesicles via LAP-competent macrophages.化疗后的凋亡乳腺癌细胞通过具有LAP活性的巨噬细胞诱导促肿瘤细胞外囊泡。
Redox Biol. 2025 Mar;80:103485. doi: 10.1016/j.redox.2024.103485. Epub 2024 Dec 28.
2
Baohuoside I chemosensitises breast cancer to paclitaxel by suppressing extracellular vesicle/CXCL1 signal released from apoptotic cells.宝藿苷 I 通过抑制凋亡细胞释放的细胞外囊泡/CXCL1 信号来增强乳腺癌对紫杉醇的化疗敏感性。
J Extracell Vesicles. 2024 Jul;13(7):e12493. doi: 10.1002/jev2.12493.
3
Tumour-derived exosomal miR-205 promotes ovarian cancer cell progression through M2 macrophage polarization via the PI3K/Akt/mTOR pathway.肿瘤来源的外泌体miR-205通过PI3K/Akt/mTOR途径促进M2巨噬细胞极化,从而推动卵巢癌细胞进展。
J Ovarian Res. 2025 Feb 15;18(1):28. doi: 10.1186/s13048-025-01616-3.
4
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.纳米治疗递送 c-myc 抑制剂靶向促肿瘤巨噬细胞并保留乳腺癌中的抗肿瘤巨噬细胞。
Theranostics. 2020 Jun 12;10(17):7510-7526. doi: 10.7150/thno.44523. eCollection 2020.
5
Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages.组蛋白去乙酰化酶抑制剂 4-苯丁酸对人巨噬细胞清除凋亡胰腺癌细胞的影响。
Int J Oncol. 2012 Feb;40(2):427-35. doi: 10.3892/ijo.2011.1239. Epub 2011 Oct 21.
6
M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.缺氧肿瘤微环境中抑瘤素 M 诱导的巨噬细胞 M2 极化是由 mTORC2 介导的,并促进肿瘤生长和转移。
Cytokine. 2019 Jun;118:130-143. doi: 10.1016/j.cyto.2018.03.032. Epub 2018 Apr 3.
7
Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression.含有热休克蛋白70的结直肠癌衍生细胞外囊泡通过上调巨噬细胞清道夫受体表达增强巨噬细胞吞噬作用。
Exp Cell Res. 2023 May 15;426(2):113565. doi: 10.1016/j.yexcr.2023.113565. Epub 2023 Mar 22.
8
Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells.埃斯克洛莫,通过 Akt 生存信号拮抗作用,增强了乳腺癌细胞中化疗药物的凋亡作用。
Breast Cancer Res Treat. 2010 Jun;121(2):311-21. doi: 10.1007/s10549-009-0470-6. Epub 2009 Jul 16.
9
SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway.SZ-685C,一种海洋蒽醌类化合物,通过抑制 Akt/FOXO 通路,是一种强效的凋亡诱导剂,具有抗癌活性。
Br J Pharmacol. 2010 Feb 1;159(3):689-97. doi: 10.1111/j.1476-5381.2009.00577.x. Epub 2010 Jan 28.
10
miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.M2 巨噬细胞来源的细胞外囊泡分泌的 miR-365 通过 BTG2/FAK/AKT 轴促进胰腺导管腺癌的进展。
J Cell Mol Med. 2021 May;25(10):4671-4683. doi: 10.1111/jcmm.16405. Epub 2021 Apr 3.

引用本文的文献

1
A multifunctional biomimetic nanoplatform combined with immune checkpoint blockade for triple-negative breast cancer immunotherapy through inhibiting polarization of M2 macrophages.一种多功能仿生纳米平台,通过抑制M2巨噬细胞极化,联合免疫检查点阻断用于三阴性乳腺癌免疫治疗。
J Nanobiotechnology. 2025 Aug 18;23(1):569. doi: 10.1186/s12951-025-03663-w.
2
Angelic acid triggers ferroptosis in colorectal cancer cells via targeting and impairing NRF2 protein stability.当归酸通过靶向并破坏NRF2蛋白稳定性来触发结肠癌细胞的铁死亡。
J Nat Med. 2025 Jan;79(1):82-94. doi: 10.1007/s11418-024-01849-4. Epub 2024 Oct 21.

本文引用的文献

1
US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With // Alterations.美国食品和药物管理局批准概要:卡培他滨联合氟维司群用于激素受体阳性、人表皮生长因子受体 2 阴性局部晚期或转移性乳腺癌伴//改变。
J Clin Oncol. 2024 Dec;42(34):4103-4113. doi: 10.1200/JCO.24.00427. Epub 2024 Aug 19.
2
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial.新辅助信迪利单抗联合放化疗治疗局部晚期胃或胃食管结合部腺癌的单臂 2 期临床试验。
Nat Commun. 2023 Aug 14;14(1):4904. doi: 10.1038/s41467-023-40480-x.
3
Advances in systemic therapies for triple negative breast cancer.三阴性乳腺癌的系统治疗进展。
BMJ. 2023 May 30;381:e071674. doi: 10.1136/bmj-2022-071674.
4
Dynamic CD8 T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes.在转移性淋巴结中,癌症免疫治疗在人体区域淋巴结中诱导的动态 CD8 T 细胞反应被打乱。
Cell. 2023 Mar 16;186(6):1127-1143.e18. doi: 10.1016/j.cell.2023.02.021.
5
Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation.牛磺胆酸-YAP1 通过 IFITM3 依赖性 AKT 激活上调 OTX1 促进胆囊癌恶性进展。
Oncogene. 2023 May;42(18):1466-1477. doi: 10.1038/s41388-023-02660-3. Epub 2023 Mar 16.
6
Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling.肿瘤相关巨噬细胞通过激活 CXCR2 信号促进肝癌细胞对索拉非尼的耐药性。
J Biomed Sci. 2022 Nov 21;29(1):99. doi: 10.1186/s12929-022-00881-4.
7
LC3-dependent EV loading and secretion (LDELS) promotes TFRC (transferrin receptor) secretion via extracellular vesicles.LC3 依赖性囊泡加载和分泌(LDELS)通过细胞外囊泡促进 TFRC(转铁蛋白受体)的分泌。
Autophagy. 2023 May;19(5):1551-1561. doi: 10.1080/15548627.2022.2140557. Epub 2022 Nov 2.
8
S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma.S100A11 通过激活磷酸戊糖途径诱导胰腺导管腺癌的恶性生物学行为。
Cell Death Dis. 2022 Jun 25;13(6):568. doi: 10.1038/s41419-022-05004-3.
9
Interleukin-17 governs hypoxic adaptation of injured epithelium.白细胞介素-17 调控受损上皮细胞的低氧适应。
Science. 2022 Jul 8;377(6602):eabg9302. doi: 10.1126/science.abg9302.
10
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.氟维司群联合卡培他滨对比安慰剂治疗激素受体阳性、HER2 阴性转移性乳腺癌患者在芳香化酶抑制剂治疗复发或进展后的疗效(FAKTION):一项随机、2 期临床试验的总生存、更新的无进展生存和扩展的生物标志物分析。
Lancet Oncol. 2022 Jul;23(7):851-864. doi: 10.1016/S1470-2045(22)00284-4. Epub 2022 Jun 4.